Incretin Action in Physiology and Diabetes
Condition:   Insulin SecretionInterventions:   Drug: GIP infusion;   Drug: GLP-1 infusion;   Drug: Ex-9 infusionSponsors:   David D'Alessio, M.D.;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruiting - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 3, 2015 Category: Research Source Type: clinical trials